Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)

Rauber, Conrad; Roberti, Maria Paula; Vehreschild, Maria J. G. T.; Tsakmaklis, Anastasia; Springfeld, Christoph; Teufel, Andreas; Ettrich, Thomas; Jochheim, Leonie; Kandulski, Arne; Missios, Pavlos; Mohr, Raphael; Reichart, Alexander; Waldschmidt, Dirk T.; Sauer, Lukas D.; Sander, Anja; Schirmacher, Peter; Jaeger, Dirk; Michl, Patrick; Dill, Michael T.

Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)

Autor(en):

Rauber, Conrad; Roberti, Maria Paula; Vehreschild, Maria J. G. T.; Tsakmaklis, Anastasia; Springfeld, Christoph; Teufel, Andreas; Ettrich, Thomas; Jochheim, Leonie; Kandulski, Arne; Missios, Pavlos; Mohr, Raphael; Reichart, Alexander; Waldschmidt, Dirk T.; Sauer, Lukas D.; Sander, Anja; Schirmacher, Peter; Jaeger, Dirk; Michl, Patrick; Dill, Michael T.

Tübinger Autor(en):

Missios, Pavlos

Erschienen in:

Bmj Open (2025), Bd. 15 (9), Article e097802

Verlagsangabe:

London : Bmj Publishing Group

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1136/bmjopen-2024-097802

ISSN:

2044-6055